Sign Up for Keystone Heart Updates
US
EU
Vision & Mission
Our Vision
Keystone Heart aspires to be the world leader in cerebral embolic protection (CEP) during cardiovascular procedures.
To develop and manufacture novel devices that protect the brain from emboli to reduce the risk of brain infarcts during transcatheter aortic valve replacement (TAVR), atrial fibrillation ablation (AF ablation), and other structural heart procedures.
Cerebral function is essential to maintaining quality of life. Preserving brain reserve during medical procedures is a key component to procedural success and patient care.